Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers
Objective Analyze the demographics, clinical characteristics, efficacy and safety of natalizumab treatment in Brazilian patients with multiple sclerosis (MS) followed up for at least 12 months, in two tertiary MS care centers in São Paulo.Method We evaluated the effect of natalizumab treatment on an...
Main Authors: | Enedina Maria Lobato de Oliveira, Renata Faria Simm, Gorana Dasic, Marília Mamprim de Morais, Samira Luiza dos Apostolos Perreira, Dagoberto Callegaro |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
2015-09-01
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900736&lng=en&tlng=en |
Similar Items
-
Evolução favorável de recidiva de infecção por varicela zoster (cobreiro) durante uso de natalizumabe em paciente com esclerose múltipla: relato de caso
by: Diego Rafhael Soares Carvalho Feitosa, et al.
Published: (2017-04-01) -
Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients
by: Luiz Henrique da Silva Nali, et al.
Published: (2014-12-01) -
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
by: Yara Dadalti Fragoso, et al.
Published: (2016-08-01) -
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive
by: Yara Dadalti Fragoso, et al.
Published: (2013-10-01) -
Increased multiple sclerosis relapses related to lower prevalence of pain
by: José Vinícius Martins da Silva, et al.
Published: (2015-07-01)